e/DeCODE genetics

New Query

Information
has glosseng: deCODE genetics, Inc. (Icelandic: Íslensk erfðagreining) is a biopharmaceutical company based in Reykjavík, Iceland. The company was founded in 1996 to identify human genes associated with common diseases using population studies, and apply the knowledge gained to guide the development of candidate drugs. So far the company has isolated genes believed to be involved in cardiovascular disease, cancer and schizophrenia, among other diseases (the company's research concerning the latter is said to represent the first time a gene has been identified by two independent studies to be associated with schizophrenia ).
lexicalizationeng: Decode Genetics
lexicalizationeng: Islensk Erfdagreining
instance ofc/Companies of Iceland
Meaning
German
has glossdeu: deCODE genetics ist ein isländisches Pharmaunternehmen mit Sitz in Reykjavík, das 1998 unter anderem von Kári Stefánsson gegründet wurde. deCODE genetics bietet - neben 23andMe und einzelnen anderen Anbietern - Privatpersonen eine Untersuchung ihrer genetischen Informationen an. Es entwickelt Medikamente und ist federführend bei der genetischen Untersuchung der Bevölkerung Islands anhand von Blut- und Gewebeproben, Familienstammbäumen und Krankenakten. Die Nutzungsrechte an den Ergebnissen erwarb im Februar 1998 Hoffmann-La Roche für 200 Mio USD. Die gesetzliche Grundlage in Island ist das Act on Biobanks.
lexicalizationdeu: DeCODE Genetics
French
has glossfra: deCODE Genetics (Íslensk erfðagreining en Islandais) est une compagnie biopharmaceutique basée à Reykjavík, Islande. La compagnie applique ses découvertes en génétique à la création de médicaments. Elle a réussi à isoler des gènes responsables de maladies telles que certaines schizophrénies ou cancers.
lexicalizationfra: DeCODE Genetics
Icelandic
has glossisl: DeCode eða Íslensk erfðagreining er íslenskt líftæknifyrirtæki sem var stofnað árið 1996. Kári Stefánsson er stjórnarformaður og forstjóri. Íslensk erfðagreining er líftæknifyrirtæki sem þróar lyf við mörgum alvarlegustu sjúkdómum samtímans eins og hjartaáföllum og blóðtappamyndun. Fyrirtækið notar erfðarannsóknir við þróun þessara lyfja, vísindamenn hafa einangrað fjölda erfðavísa sem eiga þátt í þessum sjúkdómum. Þannig komast þau að líffræðilegum orsökum þeirra og skilgreina lyf út frá því. Nú er unnið að lyfjum við hjartaáföllum, blóðtappamyndunum og astma.
lexicalizationisl: Íslensk erfðagreining
Media
geo locgeographic location 64.13555555555556 -21.945833333333333
media:imgDecodeiceland.gif

Query

Word: (case sensitive)
Language: (ISO 639-3 code, e.g. "eng" for English)


Lexvo © 2008-2025 Gerard de Melo.   Contact   Legal Information / Imprint